ArticleJournal of Crohn's & colitis2024

Corrigendum to: Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.

No numbers read from the abstract.

Not cited yet